10-Q · 2026-11-05
C4 Therapeutics, Inc. shares its Q3 earnings, emphasizing advancements in its biological products and future growth strategies.
| Name | C4 Therapeutics, Inc. |
|---|---|
| CIK | 0001662579 |
| Tickers | CCCC |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 475617627 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (617) 231-0700 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
C4 Therapeutics, Inc. shares its Q3 earnings, emphasizing advancements in its biological products and future growth strategies.
C4 Therapeutics announces third-quarter results, emphasizing progress in cemsidomide clinical trials and upcoming milestones for 2027.
552 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000277 | 005-91763 | 261562632 | 34 | 15772 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002050709-26-000030 | 005-91763 | 261557842 | 34 | 81502 | |||
| 2026-11-13 | 4 | FORM 4 | 0001470831-26-001003 | 5402 | ||||||
| 2026-11-12 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011041 | 001-39567 | 261547388 | 33 | 5015 | |||
| 2026-11-05 | 10-Q | 10-Q | 0001628280-26-070575 | 001-39567 | 261524792 | 34 | 7019231 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-070560 | 001-39567 | 261524761 | 34 | 2051378 | 1 | 1 |
| 2026-10-02 | 4 | FORM 4 | 0001470831-26-000925 | 10099 | ||||||
| 2026-10-02 | 4 | FORM 4 | 0001470831-26-000924 | 5139 | ||||||
| 2026-09-25 | 8-K | 8-K | 7.01,8.01,9.01 | 0001628280-26-063497 | 001-39567 | 261406242 | 34 | 5543089 | 1 | 1 |
| 2026-09-21 | 4 | FORM 4 | 0001470831-26-000895 | 6751 | ||||||
| 2026-08-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008193 | 001-39567 | 261284297 | 33 | 7546 | |||
| 2026-08-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008190 | 001-39567 | 261284240 | 33 | 7063 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000920 | 005-91763 | 261282949 | 34 | 15709 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-003524 | 005-91763 | 261282669 | 34 | 12662 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002050709-26-000022 | 005-91763 | 261279001 | 34 | 81464 | |||
| 2026-08-13 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008065 | 001-39567 | 261273718 | 33 | 6210 | |||
| 2026-08-12 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008039 | 001-39567 | 261268931 | 33 | 5465 | |||
| 2026-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000895421-26-000231 | 005-91763 | 261268214 | 34 | 13803 | |||
| 2026-08-11 | 10-Q | 10-Q | 0001628280-26-055494 | 001-39567 | 261260617 | 34 | 31031808 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-055490 | 001-39567 | 261260604 | 34 | 238699 | 1 | 1 |
| 2026-07-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002217 | 005-91763 | 261206114 | 34 | 10837 | |||
| 2026-07-13 | 4 | FORM 4 | 0001470831-26-000705 | 6714 | ||||||
| 2026-07-02 | 4 | FORM 4 | 0001470831-26-000688 | 10096 | ||||||
| 2026-07-02 | 4 | FORM 4 | 0001470831-26-000689 | 5136 | ||||||
| 2026-06-26 | 4 | FORM 4 | 0001470831-26-000673 | 5529 | ||||||
| 2026-06-26 | 4 | FORM 4 | 0001470831-26-000670 | 5562 | ||||||
| 2026-06-26 | 4 | FORM 4 | 0001470831-26-000667 | 5575 | ||||||
| 2026-06-26 | 4 | FORM 4 | 0001470831-26-000665 | 5568 | ||||||
| 2026-06-26 | 4 | FORM 4 | 0001470831-26-000663 | 5595 | ||||||
| 2026-06-26 | 4 | FORM 4 | 0001470831-26-000661 | 5533 | ||||||
| 2026-06-26 | 4 | FORM 4 | 0001470831-26-000659 | 5554 | ||||||
| 2026-06-26 | 4 | FORM 4 | 0001470831-26-000657 | 5519 | ||||||
| 2026-06-24 | 8-K | 8-K | 5.07,9.01 | 0001628280-26-045194 | 001-39567 | 261116140 | 34 | 402942 | 1 | 1 |
| 2026-06-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0001628280-26-042365 | 001-39567 | 261081424 | 34 | 6666645 | 1 | 1 |
| 2026-06-04 | 4 | FORM 4 | 0001470831-26-000504 | 11903 | ||||||
| 2026-05-28 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-245847 | 001-39567 | 261038622 | 33 | 4397 | |||
| 2026-05-19 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002050709-26-000018 | 005-91763 | 26998725 | 34 | 80756 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003479 | 005-91763 | 26988031 | 34 | 12394 | |||
| 2026-05-15 | 8-K | 8-K | 5.02 | 0001628280-26-035542 | 001-39567 | 26986814 | 34 | 148084 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003216 | 005-91763 | 26982441 | 34 | 19052 | |||
| 2026-05-12 | 10-Q | 10-Q | 0001628280-26-033865 | 001-39567 | 26965845 | 34 | 6307083 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-26-033861 | 001-39567 | 26965830 | 34 | 3995449 | 1 | 1 |
| 2026-04-29 | ARS | ARS | 0001628280-26-028109 | 001-39567 | 26910490 | 34 | 52619850 | |||
| 2026-04-29 | DEFA14A | DEFA14A | 0001628280-26-028108 | 001-39567 | 26910487 | 34 | 1301766 | |||
| 2026-04-29 | DEF 14A | DEF 14A | 0001628280-26-028104 | 001-39567 | 26910467 | 34 | 4032125 | 1 | 1 | |
| 2026-04-22 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000814133-26-000050 | 005-91763 | 26884831 | 34 | 7388 | |||
| 2026-04-10 | 8-K | 8-K | 5.03,9.01 | 0001628280-26-024583 | 001-39567 | 26853143 | 34 | 421423 | 1 | 1 |
| 2026-04-09 | 8-K | 8-K | 1.01,7.01,9.01 | 0001628280-26-024336 | 001-39567 | 26849797 | 34 | 4308825 | 1 | 1 |
| 2026-04-03 | 4 | FORM 4 | 0001470831-26-000346 | 10096 | ||||||
| 2026-04-03 | 4 | FORM 4 | 0001470831-26-000345 | 5136 | ||||||
| 2026-03-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-002361 | 001-39567 | 26735253 | 33 | 5473 | |||
| 2026-02-26 | S-8 | S-8 | 0001628280-26-012002 | 333-293775 | 26681751 | 33 | 234993 | 1 | 1 | |
| 2026-02-26 | 10-K | 10-K | 0001628280-26-012000 | 001-39567 | 26681746 | 34 | 12544005 | 1 | 1 | |
| 2026-02-26 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-011971 | 001-39567 | 26681683 | 34 | 241350 | 1 | 1 |
| 2026-02-18 | 4 | FORM 4 | 0001470831-26-000180 | 11467 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0001470831-26-000179 | 8523 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0001470831-26-000178 | 11462 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0001470831-26-000177 | 376948 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0001470831-26-000176 | 8511 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0001470831-26-000175 | 11467 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0001470831-26-000174 | 8533 | ||||||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947871-26-000188 | 005-91763 | 26644171 | 34 | 15262 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001046 | 005-91763 | 26639369 | 34 | 10521 | |||
| 2026-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-26-015656 | 005-91763 | 26627424 | 34 | 31618 | |||
| 2026-02-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-26-000033 | 005-91763 | 26619621 | 34 | 11861 | |||
| 2026-01-16 | 4 | FORM 4 | 0001470831-26-000045 | 4511 | ||||||
| 2026-01-14 | 8-K | 8-K | 7.01,9.01 | 0001628280-26-002010 | 001-39567 | 26531449 | 34 | 195715 | 1 | 1 |
| 2026-01-05 | 4 | FORM 4 | 0001470831-26-000009 | 372190 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0001470831-26-000008 | 5002 | ||||||
| 2025-12-10 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003638 | 333-291696 | 251563394 | 33 | 1765 | ||
| 2025-12-10 | 424B5 | 424B5 | 0001193125-25-314449 | 333-291696 | 251562890 | 33 | 388977 | |||
| 2025-12-08 | CORRESP | filename1.htm | 0001628280-25-055804 | 12228 | ||||||
| 2025-11-21 | S-3 | S-3 | 0001628280-25-053575 | 333-291696 | 251507867 | 33 | 27489258 | 1 | 1 | |
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947871-25-001020 | 005-91763 | 251488585 | 34 | 15160 | |||
| 2025-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000814133-25-000117 | 005-91763 | 251479957 | 34 | 6395 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001628280-25-049854 | 001-39567 | 251456124 | 34 | 6659448 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-049850 | 001-39567 | 251456106 | 34 | 240318 | 1 | 1 |
| 2025-10-30 | 4 | 4 | 0001193125-25-258664 | 6406 | ||||||
| 2025-10-24 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950130-25-000220 | 005-91763 | 251416535 | 34 | 135702 | |||
| 2025-10-24 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-25-000025 | 005-91763 | 251416337 | 34 | 20075 | |||
| 2025-10-20 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004471 | 005-91763 | 251404988 | 34 | 21303 | |||
| 2025-10-16 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-241591 | 001-39567 | 251398485 | 34 | 861664 | 1 | 1 |
| 2025-10-16 | 424B5 | 424B5 | 0001193125-25-241586 | 333-282933 | 251398482 | 33 | 560613 | |||
| 2025-10-16 | FWP | FWP | 0001193125-25-240800 | 333-282933 | 251396363 | 34 | 153176 | |||
| 2025-10-16 | 8-K | 8-K | 8.01 | 0001628280-25-045157 | 001-39567 | 251396350 | 34 | 5254707 | 1 | 1 |
| 2025-10-03 | 4 | FORM 4 | 0001470831-25-000250 | 9743 | ||||||
| 2025-10-03 | 4 | FORM 4 | 0001470831-25-000249 | 5003 | ||||||
| 2025-10-01 | 8-K | 8-K | 7.01,8.01,9.01 | 0001628280-25-043290 | 001-39567 | 251362549 | 34 | 178493 | 1 | 1 |
| 2025-09-22 | 8-K | 8-K | 7.01,8.01,9.01 | 0001628280-25-042245 | 001-39567 | 251328367 | 34 | 6380449 | 1 | 1 |
| 2025-09-19 | 4 | FORM 4 | 0001470831-25-000223 | 6614 | ||||||
| 2025-08-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000489 | 005-91763 | 251192833 | 34 | 7938 | |||
| 2025-08-07 | 10-Q | 10-Q | 0001628280-25-038587 | 001-39567 | 251191564 | 34 | 6350858 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001628280-25-038576 | 001-39567 | 251191526 | 34 | 3863925 | 1 | 1 |
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002489 | 005-91763 | 251128457 | 34 | 10800 | |||
| 2025-07-15 | 4/A | FORM 4/A | 0001662579-25-000057 | 6750 | ||||||
| 2025-07-14 | 4 | FORM 4 | 0001662579-25-000055 | 4817 | ||||||
| 2025-07-02 | 4 | FORM 4 | 0001662579-25-000053 | 9740 | ||||||
| 2025-07-02 | 4 | FORM 4 | 0001662579-25-000052 | 5000 | ||||||
| 2025-06-20 | 4 | FORM 4 | 0001662579-25-000049 | 5439 | ||||||
| 2025-06-20 | 4 | FORM 4 | 0001662579-25-000048 | 5408 | ||||||
| 2025-06-20 | 4 | FORM 4 | 0001662579-25-000047 | 5418 | ||||||
| 2025-06-20 | 4 | FORM 4 | 0001662579-25-000046 | 5432 | ||||||
| 2025-06-20 | 4 | FORM 4 | 0001662579-25-000045 | 5397 | ||||||
| 2025-06-20 | 4 | FORM 4 | 0001662579-25-000044 | 5383 | ||||||
| 2025-06-20 | 4 | FORM 4 | 0001662579-25-000043 | 5459 | ||||||
| 2025-06-20 | 4 | FORM 4 | 0001662579-25-000042 | 5426 | ||||||
| 2025-06-18 | 8-K | 8-K | 5.03,5.07,9.01 | 0001628280-25-032155 | 001-39567 | 251057568 | 34 | 466405 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947871-25-000543 | 005-91763 | 25956616 | 34 | 14940 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-013188 | 005-91763 | 25954917 | 34 | 17051 | |||
| 2025-05-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000814133-25-000035 | 005-91763 | 25920509 | 34 | 6542 | |||
| 2025-05-07 | 10-Q | 10-Q | 0001628280-25-022866 | 001-39567 | 25919252 | 34 | 6073473 | 1 | 1 | |
| 2025-05-07 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001628280-25-022864 | 001-39567 | 25919244 | 34 | 4276315 | 1 | 1 |
| 2025-04-29 | ARS | ARS | 0001628280-25-020468 | 001-39567 | 25882612 | 34 | 53299356 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0001628280-25-020467 | 001-39567 | 25882601 | 34 | 2258170 | 1 | 1 | |
| 2025-04-29 | DEF 14A | DEF 14A | 0001628280-25-020466 | 001-39567 | 25882596 | 34 | 2447327 | 1 | 1 | |
| 2025-04-16 | PRE 14A | PRE 14A | 0001628280-25-017927 | 001-39567 | 25841241 | 34 | 2414807 | 1 | 1 | |
| 2025-04-14 | 8-K | 8-K | 5.02 | 0001628280-25-017612 | 001-39567 | 25834266 | 34 | 150960 | 1 | 1 |
| 2025-04-03 | 4 | FORM 4 | 0001662579-25-000025 | 5001 | ||||||
| 2025-04-03 | 4 | FORM 4 | 0001662579-25-000024 | 9741 | ||||||
| 2025-02-27 | S-8 | S-8 | 0001628280-25-008434 | 333-285304 | 25672994 | 33 | 138830 | |||
| 2025-02-27 | 10-K | 10-K | 0001628280-25-008433 | 001-39567 | 25672983 | 34 | 31568329 | 1 | 1 | |
| 2025-02-27 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-008429 | 001-39567 | 25672960 | 34 | 254988 | 1 | 1 |
| 2025-02-18 | 4 | FORM 4 | 0001662579-25-000021 | 10204 | ||||||
| 2025-02-18 | 4 | FORM 4 | 0001662579-25-000020 | 10205 | ||||||
| 2025-02-18 | 4 | FORM 4 | 0001662579-25-000019 | 13160 | ||||||
| 2025-02-18 | 4 | FORM 4 | 0001662579-25-000018 | 4855 | ||||||
| 2025-02-18 | 4 | FORM 4 | 0001662579-25-000017 | 10205 | ||||||
| 2025-02-18 | 4 | FORM 4 | 0001662579-25-000016 | 10212 | ||||||
| 2025-02-18 | 4 | FORM 4 | 0001662579-25-000015 | 7187 | ||||||
| 2025-02-18 | 4 | FORM 4 | 0001662579-25-000014 | 8780 | ||||||
| 2025-02-03 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000188 | 005-91763 | 25581835 | 34 | 7832 | |||
| 2025-01-14 | 8-K | 8-K | 2.02,7.01 | 0001628280-25-001433 | 001-39567 | 25527748 | 34 | 5922538 | 1 | 1 |
| 2025-01-03 | 4 | FORM 4 | 0001662579-25-000004 | 5009 | ||||||
| 2025-01-03 | 4 | FORM 4 | 0001662579-25-000003 | 9749 | ||||||
| 2024-12-09 | 8-K | 8-K | 8.01,9.01 | 0001628280-24-050349 | 001-39567 | 241534072 | 34 | 10827866 | 1 | 1 |
| 2024-11-21 | 4 | FORM 4 | 0001662579-24-000108 | 5437 | ||||||
| 2024-11-21 | 3 | FORM 3 | 0001662579-24-000107 | 7418 | ||||||
| 2024-11-20 | 8-K | 8-K | 5.02,7.01,9.01 | 0001628280-24-048593 | 001-39567 | 241478271 | 34 | 186520 | 1 | 1 |
| 2024-11-18 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001664 | 001-39567 | 241472052 | 33 | 5560 | |||
| 2024-11-15 | 424B3 | 424B3 | 0001628280-24-048091 | 333-282934 | 241467850 | 33 | 187777 | |||
| 2024-11-15 | 424B5 | 424B5 | 0001628280-24-048088 | 333-282933 | 241467819 | 33 | 158439 | |||
| 2024-11-14 | SC 13G/A | C4 THERAPEUTICS, INC. | 0000902664-24-006655 | 005-91763 | 241465310 | 34 | 76258 | |||
| 2024-11-14 | SC 13G | SCHEDULE 13G | 0000947871-24-000915 | 005-91763 | 241465072 | 34 | 68688 | |||
| 2024-11-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-045843 | 005-91763 | 241461869 | 34 | 90877 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-098320 | 005-91763 | 241461018 | 34 | 136320 | |||
| 2024-11-14 | SC 13G/A | cccc13gasep24.txt | 0000080255-24-001455 | 005-91763 | 34 | 6688 | ||||
| 2024-11-14 | SC 13G/A | C4 THERAPEUTICS, INC. | 0000902664-24-006516 | 005-91763 | 241457607 | 34 | 66671 | |||
| 2024-11-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-11-13 16:05:00 | 9999999995-24-003480 | 333-282934 | 241456695 | 33 | 1772 | ||
| 2024-11-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-11-13 16:05:00 | 9999999995-24-003479 | 333-282933 | 241456694 | 33 | 1772 | ||
| 2024-11-13 | SUPPL | SUPPL | 0001628280-24-047659 | 333-282933 | 241455374 | NE | 158467 | |||
| 2024-11-13 | SUPPL | SUPPL | 0001628280-24-047658 | 333-282934 | 241455368 | NE | 195133 | |||
| 2024-11-12 | 4 | FORM 4 | 0001662579-24-000104 | 8597 | ||||||
| 2024-11-12 | 4 | FORM 4 | 0001662579-24-000103 | 8596 | ||||||
| 2024-11-12 | 4 | FORM 4 | 0001662579-24-000102 | 8592 | ||||||
| 2024-11-12 | 4 | FORM 4 | 0001662579-24-000101 | 8576 | ||||||
| 2024-11-12 | 4 | FORM 4 | 0001662579-24-000100 | 8593 | ||||||
| 2024-11-08 | CORRESP | filename1.htm | 0001628280-24-046658 | 27854 | ||||||
| 2024-11-08 | CORRESP | filename1.htm | 0001628280-24-046657 | 27856 | ||||||
| 2024-11-08 | SC 13G | us12529r1077_110824.txt | 0002012383-24-003684 | 005-91763 | 241439838 | 34 | 13731 | |||
| 2024-11-07 | UPLOAD | filename1.pdf | 0000000000-24-012425 | 333-282934 | 40153 | |||||
| 2024-11-07 | UPLOAD | filename1.pdf | 0000000000-24-012423 | 333-282933 | 40155 | |||||
| 2024-10-31 | S-3 | S-3 | 0001628280-24-044613 | 333-282934 | 241416287 | 33 | 359411 | |||
| 2024-10-31 | S-3 | S-3 | 0001628280-24-044612 | 333-282933 | 241416286 | 33 | 43124847 | |||
| 2024-10-31 | 10-Q | 10-Q | 0001628280-24-044411 | 001-39567 | 241412411 | 34 | 6389876 | 1 | 1 | |
| 2024-10-31 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-044409 | 001-39567 | 241412401 | 34 | 260009 | 1 | 1 |
| 2024-10-29 | 4 | FORM 4 | 0001662579-24-000094 | 7330 | ||||||
| 2024-10-29 | 3 | FORM 3 | 0001662579-24-000092 | 7487 | ||||||
| 2024-10-22 | SC 13G | us12529r1077_102224.txt | 0002012383-24-001634 | 005-91763 | 241387359 | 34 | 13719 | |||
| 2024-10-18 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001412 | 001-39567 | 241381208 | 33 | 4878 | |||
| 2024-10-16 | 8-K/A | 8-K/A | 5.02,7.01,9.01 | 0001628280-24-042879 | 001-39567 | 241372901 | 34 | 3113559 | 1 | 1 |
| 2024-10-15 | 8-K | 8-K | 5.02,7.01,9.01 | 0001628280-24-042833 | 001-39567 | 241371958 | 34 | 3111505 | 1 | 1 |
| 2024-10-11 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001402 | 001-39567 | 241368572 | 33 | 4270 | |||
| 2024-10-11 | 8-K | 8-K | 5.02,9.01 | 0001628280-24-042728 | 001-39567 | 241367662 | 34 | 417221 | 1 | 1 |
| 2024-10-02 | 4 | FORM 4 | 0001662579-24-000090 | 5014 | ||||||
| 2024-10-02 | 4 | FORM 4 | 0001662579-24-000089 | 9750 | ||||||
| 2024-09-20 | 4 | FORM 4 | 0001662579-24-000086 | 4836 | ||||||
| 2024-09-17 | 4 | FORM 4 | 0001662579-24-000084 | 8590 | ||||||
| 2024-09-17 | 4 | FORM 4 | 0001662579-24-000083 | 8596 | ||||||
| 2024-09-17 | 4 | FORM 4 | 0001662579-24-000082 | 8595 | ||||||
| 2024-09-17 | 4 | FORM 4 | 0001662579-24-000081 | 8602 | ||||||
| 2024-09-17 | 4 | FORM 4 | 0001662579-24-000080 | 8591 | ||||||
| 2024-09-17 | 4 | FORM 4 | 0001662579-24-000079 | 8575 | ||||||
| 2024-09-03 | 4 | FORM 4 | 0001662579-24-000072 | 5427 | ||||||
| 2024-09-03 | 3 | FORM 3 | 0001662579-24-000070 | 7407 | ||||||
| 2024-09-03 | 8-K | 8-K | 5.02,7.01,9.01 | 0001628280-24-039023 | 001-39567 | 241271885 | 34 | 193001 | 1 | 1 |
| 2024-08-01 | 10-Q | 10-Q | 0001628280-24-033882 | 001-39567 | 241164275 | 34 | 5916841 | 1 | 1 | |
| 2024-08-01 | 8-K | 8-K | 2.02 | 0001628280-24-033874 | 001-39567 | 241164245 | 34 | 248745 | 1 | 1 |
| 2024-07-11 | 4 | FORM 4 | 0001662579-24-000066 | 4821 | ||||||
| 2024-07-10 | SC 13G/A | C4_Therapeutics_Inc.txt | 0000093751-24-000658 | 005-91763 | 241108656 | 34 | 8429 | |||
| 2024-07-02 | 4 | FORM 4 | 0001662579-24-000064 | 5007 | ||||||
| 2024-07-02 | 4 | FORM 4 | 0001662579-24-000063 | 9747 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001662579-24-000060 | 5415 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001662579-24-000059 | 5404 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001662579-24-000058 | 5446 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001662579-24-000057 | 5280 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001662579-24-000056 | 5425 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001662579-24-000055 | 5439 | ||||||
| 2024-06-21 | 8-K | 8-K | 5.07 | 0001628280-24-029301 | 001-39567 | 241060199 | 34 | 167453 | 1 | 1 |
| 2024-06-21 | 4 | FORM 4 | 0001662579-24-000054 | 5390 | ||||||
| 2024-06-11 | 4 | FORM 4 | 0001662579-24-000046 | 5465 | ||||||
| 2024-06-11 | 3 | FORM 3 | 0001662579-24-000044 | 7443 | ||||||
| 2024-06-10 | 8-K | 8-K | 5.02,7.01,9.01 | 0001628280-24-027399 | 001-39567 | 241031479 | 34 | 191224 | 1 | 1 |
| 2024-05-08 | 10-Q | 10-Q | 0001628280-24-021368 | 001-39567 | 24924224 | 34 | 24256688 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-021367 | 001-39567 | 24924215 | 34 | 236760 | 1 | 1 |
| 2024-04-30 | ARS | ARS | 0001628280-24-019204 | 001-39567 | 24894201 | 34 | 53011987 | |||
| 2024-04-29 | DEFA14A | DEFA14A | 0001628280-24-018787 | 001-39567 | 24886677 | 34 | 463577 | 1 | 1 | |
| 2024-04-29 | DEF 14A | DEF 14A | 0001628280-24-018785 | 001-39567 | 24886672 | 34 | 2568449 | 1 | 1 | |
| 2024-04-10 | 4 | FORM 4 | 0001662579-24-000040 | 7393 | ||||||
| 2024-04-10 | SC 13G | C4_Therapeutics_Inc.txt | 0000093751-24-000578 | 005-91763 | 24834425 | 34 | 10261 | |||
| 2024-04-02 | 4 | FORM 4 | 0001662579-24-000038 | 9747 | ||||||
| 2024-04-02 | 4 | FORM 4 | 0001662579-24-000037 | 7277 | ||||||
| 2024-04-02 | 4 | FORM 4 | 0001662579-24-000036 | 5007 | ||||||
| 2024-03-08 | 4 | FORM 4 | 0001662579-24-000032 | 7889 | ||||||
| 2024-03-08 | 4 | FORM 4 | 0001662579-24-000030 | 12248 | ||||||
| 2024-03-08 | 4 | FORM 4 | 0001662579-24-000028 | 12270 | ||||||
| 2024-03-08 | 4 | FORM 4 | 0001662579-24-000026 | 7918 | ||||||
| 2024-03-08 | 4 | FORM 4 | 0001662579-24-000024 | 12218 | ||||||
| 2024-03-08 | 8-K | 8-K | 5.02 | 0001628280-24-009967 | 001-39567 | 24734425 | 34 | 160498 | 1 | 1 |
| 2024-03-08 | SC 13G/A | cccc324.txt | 0000814133-24-000064 | 005-91763 | 24733403 | 34 | 4163 | |||
| 2024-03-04 | 8-K | 8-K | 1.01,7.01,9.01 | 0001628280-24-008339 | 001-39567 | 24712822 | 34 | 194393 | 1 | 1 |
| 2024-02-22 | S-8 | S-8 | 0001628280-24-006168 | 333-277245 | 24662481 | 33 | 135225 | |||
| 2024-02-22 | 10-K | 10-K | 0001628280-24-006144 | 001-39567 | 24662289 | 34 | 39472722 | 1 | 1 | |
| 2024-02-22 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-006142 | 001-39567 | 24662281 | 34 | 246205 | 1 | 1 |
| 2024-02-15 | 4 | FORM 4 | 0001662579-24-000022 | 4847 | ||||||
| 2024-02-15 | 4 | FORM 4 | 0001662579-24-000020 | 7174 | ||||||
| 2024-02-15 | 4 | FORM 4 | 0001662579-24-000019 | 7149 | ||||||
| 2024-02-15 | 4 | FORM 4 | 0001662579-24-000018 | 8787 | ||||||
| 2024-02-15 | 4 | FORM 4 | 0001662579-24-000017 | 8803 | ||||||
| 2024-02-15 | 4 | FORM 4 | 0001662579-24-000016 | 8814 | ||||||
| 2024-02-15 | 4 | FORM 4 | 0001662579-24-000015 | 8808 | ||||||
| 2024-02-15 | 4 | FORM 4 | 0001662579-24-000014 | 8807 | ||||||
| 2024-02-14 | SC 13G/A | cccc13gadec23.txt | 0000080255-24-000751 | 005-91763 | 34 | 6505 | ||||
| 2024-02-14 | SC 13G/A | C4 THERAPEUTICS, INC. | 0000902664-24-001611 | 005-91763 | 24633037 | 34 | 64723 | |||
| 2024-02-14 | SC 13G/A | C4 THERAPEUTICS, INC. | 0000902664-24-001562 | 005-91763 | 24632321 | 34 | 61958 | |||
| 2024-02-09 | SC 13G/A | cccc224.txt | 0000814133-24-000028 | 005-91763 | 24613683 | 34 | 4165 | |||
| 2024-02-05 | SC 13G | SCHEDULE 13G | 0001213900-24-009888 | 005-91763 | 24594423 | 34 | 110754 | |||
| 2024-02-02 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-009358 | 005-91763 | 24589019 | 34 | 99176 | |||
| 2024-01-12 | SC 13G | SC 13G | 0001193125-24-007490 | 005-91763 | 24532040 | 34 | 61436 | |||
| 2024-01-11 | 8-K | 8-K | 7.01,9.01 | 0001628280-24-001085 | 001-39567 | 24527952 | 34 | 4726312 | 1 | 1 |
| 2024-01-09 | 8-K | 8-K | 2.05,7.01,9.01 | 0001628280-24-000947 | 001-39567 | 24523307 | 34 | 218326 | 1 | 1 |
| 2024-01-04 | SC 13G | C4 THERAPEUTICS, INC. | 0000902664-24-000047 | 005-91763 | 24512053 | 34 | 85161 | |||
| 2024-01-03 | 4 | FORM 4 | 0001662579-24-000006 | 7279 | ||||||
| 2024-01-03 | 4 | FORM 4 | 0001662579-24-000005 | 9749 | ||||||
| 2024-01-03 | 4 | FORM 4 | 0001662579-24-000004 | 5009 | ||||||
| 2023-12-26 | SC 13G | SC 13G | 0001104659-23-129222 | 005-91763 | 231513661 | 34 | 82985 | |||
| 2023-12-22 | SC 13G | formsc13g.htm | 0001493152-23-045910 | 005-91763 | 231509776 | 34 | 97989 | |||
| 2023-12-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001628280-23-041317 | 001-39567 | 231481562 | 34 | 5495404 | 1 | 1 |
| 2023-12-12 | 8-K | 8-K | 1.01,7.01,9.01 | 0001628280-23-041271 | 001-39567 | 231479945 | 34 | 196167 | 1 | 1 |
| 2023-11-20 | 4 | FORM 4 | 0001662579-23-000114 | 5338 | ||||||
| 2023-11-20 | 3 | FORM 3 | 0001662579-23-000112 | 7312 | ||||||
| 2023-11-20 | 8-K | 8-K | 5.02,7.01,9.01 | 0001628280-23-039562 | 001-39567 | 231420697 | 34 | 191445 | 1 | 1 |
| 2023-11-13 | SC 13G | C4 THERAPEUTICS, INC. | 0000902664-23-005480 | 005-91763 | 231399764 | 34 | 67844 | |||
| 2023-11-01 | 10-Q | 10-Q | 0001628280-23-035793 | 001-39567 | 231366576 | 34 | 7506694 | 1 | 1 | |
| 2023-11-01 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-035790 | 001-39567 | 231366559 | 34 | 256673 | 1 | 1 |
| 2023-10-03 | 4 | FORM 4 | 0001662579-23-000109 | 9668 | ||||||
| 2023-10-03 | 4 | FORM 4 | 0001662579-23-000108 | 7198 | ||||||
| 2023-10-03 | 4 | FORM 4 | 0001662579-23-000107 | 4928 | ||||||
| 2023-09-19 | 4 | FORM 4 | 0001662579-23-000102 | 5270 | ||||||
| 2023-09-19 | 4 | FORM 4 | 0001662579-23-000101 | 5275 | ||||||
| 2023-09-19 | 4 | FORM 4 | 0001662579-23-000100 | 5284 | ||||||
| 2023-09-19 | 4 | FORM 4 | 0001662579-23-000099 | 5280 | ||||||
| 2023-09-19 | 4 | FORM 4 | 0001662579-23-000098 | 5259 | ||||||
| 2023-09-19 | 4 | FORM 4 | 0001662579-23-000097 | 7213 | ||||||
| 2023-09-19 | 3 | FORM 3 | 0001662579-23-000096 | 8672 | ||||||
| 2023-09-19 | 3 | FORM 3 | 0001662579-23-000095 | 13676 | ||||||
| 2023-09-05 | 8-K | 8-K | 5.02,9.01 | 0001628280-23-031375 | 001-39567 | 231235664 | 34 | 6400968 | 1 | 1 |
| 2023-08-31 | 4 | FORM 4 | 0001662579-23-000086 | 8508 | ||||||
| 2023-08-31 | 4 | FORM 4 | 0001662579-23-000085 | 8493 | ||||||
| 2023-08-31 | 4 | FORM 4 | 0001662579-23-000084 | 8513 | ||||||
| 2023-08-31 | 4 | FORM 4 | 0001662579-23-000083 | 8509 | ||||||
| 2023-08-31 | 4 | FORM 4 | 0001662579-23-000082 | 8520 | ||||||
| 2023-08-31 | 4 | FORM 4 | 0001662579-23-000081 | 8514 | ||||||
| 2023-08-08 | 10-Q | 10-Q | 0001628280-23-027941 | 001-39567 | 231149306 | 34 | 5855395 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-027935 | 001-39567 | 231149278 | 34 | 261729 | 1 | 1 |
| 2023-07-25 | SC 13G | CCCC_SC13G.htm | 0001273087-23-000125 | 005-91763 | 231109065 | 34 | 82051 | |||
| 2023-07-12 | 4 | FORM 4 | 0001662579-23-000074 | 7207 | ||||||
| 2023-07-12 | 3 | FORM 3 | 0001662579-23-000073 | 7370 | ||||||
| 2023-07-07 | SC 13G/A | us12529r1077_070723.txt | 0001306550-23-009607 | 005-91763 | 231077274 | 34 | 12486 | |||
| 2023-07-05 | 4 | FORM 4 | 0001662579-23-000068 | 9665 | ||||||
| 2023-07-05 | 4 | FORM 4 | 0001662579-23-000067 | 7196 | ||||||
| 2023-07-05 | 4 | FORM 4 | 0001662579-23-000066 | 4926 | ||||||
| 2023-06-20 | 8-K | 8-K | 5.02,5.07,9.01 | 0001628280-23-022597 | 001-39567 | 231023363 | 34 | 237626 | 1 | 1 |
| 2023-06-16 | 4 | FORM 4 | 0001662579-23-000062 | 5357 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001662579-23-000061 | 5322 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001662579-23-000060 | 5198 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001662579-23-000059 | 5358 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001662579-23-000058 | 5308 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001662579-23-000057 | 5364 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001662579-23-000055 | 5343 | ||||||
| 2023-06-12 | SC 13G/A | arrowmark-cccc053123a2.htm | 0001172661-23-002371 | 005-91763 | 231008209 | 34 | 54172 | |||
| 2023-05-30 | 8-K | 8-K | 1.01,3.02,9.01 | 0001628280-23-020025 | 001-39567 | 23971395 | 34 | 1367811 | 1 | 1 |
| 2023-05-04 | 10-Q | 10-Q | 0001628280-23-015459 | 001-39567 | 23886567 | 34 | 6281089 | 1 | 1 | |
| 2023-05-04 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-015454 | 001-39567 | 23886508 | 34 | 253217 | 1 | 1 |
| 2023-05-03 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001628280-23-004824,2023-05-03 | 9999999995-23-001249 | 333-260972 | 23886160 | 33 | 1735 | ||
| 2023-04-28 | ARS | ARS | 0001628280-23-013742 | 001-39567 | 23860093 | 34 | 41391984 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0001628280-23-013741 | 001-39567 | 23860085 | 34 | 545373 | 1 | 1 | |
| 2023-04-28 | DEF 14A | DEF 14A | 0001628280-23-013738 | 001-39567 | 23860077 | 34 | 2295706 | 1 | 1 | |
| 2023-04-18 | PRE 14A | PRE 14A | 0001628280-23-011846 | 001-39567 | 23825516 | 34 | 2308820 | 1 | 1 | |
| 2023-04-14 | SC 13G | SC 13G | 0001193125-23-102252 | 005-91763 | 23821966 | 34 | 107265 | |||
| 2023-04-04 | 4 | FORM 4 | 0001662579-23-000046 | 7277 | ||||||
| 2023-04-04 | 4 | FORM 4 | 0001662579-23-000045 | 9747 | ||||||
| 2023-04-04 | 4 | FORM 4 | 0001662579-23-000044 | 5007 | ||||||
| 2023-02-23 | 8-K/A | 8-K/A | 2.02,9.01 | 0001628280-23-004835 | 001-39567 | 23659897 | 34 | 248460 | 1 | 1 |
| 2023-02-23 | S-8 | S-8 | 0001628280-23-004830 | 333-269944 | 23659858 | 33 | 97065 | |||
| 2023-02-23 | POS AM | POS AM | 0001628280-23-004824 | 333-260972 | 23659739 | 33 | 476845 | |||
| 2023-02-23 | 10-K | 10-K | 0001628280-23-004711 | 001-39567 | 23656280 | 34 | 16051745 | 1 | 1 | |
| 2023-02-23 | POSASR | POSASR | 0001628280-23-004707 | 333-260972 | 23656065 | 33 | 578492 | |||
| 2023-02-23 | 8-K | 8-K | 2.02,9.01 | 0001662579-23-000040 | 001-39567 | 23655971 | 34 | 249109 | 1 | 1 |
| 2023-02-15 | 4 | FORM 4 | 0001662579-23-000039 | 7116 | ||||||
| 2023-02-15 | 4 | FORM 4 | 0001662579-23-000038 | 7087 | ||||||
| 2023-02-15 | 4 | FORM 4 | 0001662579-23-000037 | 7108 | ||||||
| 2023-02-15 | 4 | FORM 4 | 0001662579-23-000036 | 7103 | ||||||
| 2023-02-15 | 4 | FORM 4 | 0001662579-23-000035 | 7110 | ||||||
| 2023-02-15 | 4 | FORM 4 | 0001662579-23-000034 | 7102 | ||||||
| 2023-02-14 | SC 13G | arrowmark-cccc123122a1.htm | 0001172661-23-001446 | 005-91763 | 23632039 | 34 | 53976 | |||
| 2023-02-14 | SC 13G/A | cccc13gadec22.txt | 0000080255-23-002715 | 005-91763 | 34 | 6865 | ||||
| 2023-02-14 | SC 13G/A | C4 THERAPEUTICS, INC. | 0000902664-23-001723 | 005-91763 | 23623855 | 34 | 62523 | |||
| 2023-02-10 | 4 | FORM 4 | 0001662579-23-000027 | 4477 | ||||||
| 2023-02-08 | SC 13G/A | cccc223.txt | 0000814133-23-000031 | 005-91763 | 23598899 | 34 | 3987 | |||
| 2023-02-02 | 8-K | 8-K | 5.02,7.01 | 0001628280-23-002041 | 001-39567 | 23580809 | 34 | 232176 | 1 | 1 |
| 2023-02-01 | 4 | FORM 4 | 0001662579-23-000024 | 8522 | ||||||
| 2023-02-01 | 4 | FORM 4 | 0001662579-23-000023 | 8522 | ||||||
| 2023-02-01 | 4 | FORM 4 | 0001662579-23-000022 | 8523 | ||||||
| 2023-02-01 | 4 | FORM 4 | 0001662579-23-000021 | 8519 | ||||||
| 2023-02-01 | 4 | FORM 4 | 0001662579-23-000020 | 8518 | ||||||
| 2023-02-01 | 4 | FORM 4 | 0001662579-23-000019 | 8502 | ||||||
| 2023-02-01 | 4 | FORM 4 | 0001662579-23-000018 | 8529 | ||||||
| 2023-01-31 | SC 13G/A | us12529r1077_013123.txt | 0001306550-23-005138 | 005-91763 | 23571789 | 34 | 13309 | |||
| 2023-01-09 | 8-K | 8-K | 7.01,9.01 | 0001628280-23-000725 | 001-39567 | 23516621 | 34 | 9802927 | 1 | 1 |
| 2023-01-06 | 4 | FORM 4 | 0001662579-23-000008 | 14935 | ||||||
| 2023-01-04 | 4 | FORM 4 | 0001662579-23-000006 | 9717 | ||||||
| 2023-01-04 | 4 | FORM 4 | 0001662579-23-000005 | 4977 | ||||||
| 2023-01-04 | 4 | FORM 4 | 0001662579-23-000004 | 7247 | ||||||
| 2022-11-03 | 10-Q | 10-Q | 0001628280-22-027985 | 001-39567 | 221356293 | 34 | 7451839 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-027966 | 001-39567 | 221356210 | 34 | 412130 | 1 | 1 |
| 2022-10-04 | 4 | FORM 4 | 0001662579-22-000006 | 4976 | ||||||
| 2022-10-04 | 4 | FORM 4 | 0001662579-22-000005 | 7248 | ||||||
| 2022-10-04 | 4 | FORM 4 | 0001662579-22-000004 | 16850 | ||||||
| 2022-09-22 | 8-K/A | 8-K/A | 5.07 | 0001628280-22-025322 | 001-39567 | 221257856 | 34 | 174570 | 1 | 1 |
| 2022-08-04 | 10-Q | 10-Q | 0001628280-22-020886 | 001-39567 | 221134875 | 34 | 7321450 | 1 | 1 | |
| 2022-08-04 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-020884 | 001-39567 | 221134843 | 34 | 412015 | 1 | 1 |
| 2022-08-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-043870 | 5317 | ||||||
| 2022-08-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-043869 | 5331 | ||||||
| 2022-08-02 | 3 | FORM 3 SUBMISSION | 0001209191-22-043864 | 7201 | ||||||
| 2022-08-02 | 3 | FORM 3 SUBMISSION | 0001209191-22-043861 | 7215 | ||||||
| 2022-08-02 | 8-K | 8-K | 5.02,7.01,9.01 | 0001628280-22-020108 | 001-39567 | 221126972 | 34 | 467928 | 1 | 1 |
| 2022-07-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-042457 | 15496 | ||||||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-040603 | 7278 | ||||||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-040597 | 9745 | ||||||
| 2022-06-24 | 8-K | 8-K | 5.07 | 0001564590-22-024179 | 001-39567 | 221039942 | 34 | 198489 | 1 | 1 |
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038865 | 5354 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038864 | 5355 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038863 | 5298 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038862 | 5340 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038861 | 5195 | ||||||
| 2022-06-17 | DEFA14A | DEFA14A | 0001564590-22-023556 | 001-39567 | 221023815 | 34 | 28880 | |||
| 2022-06-17 | 8-K | 8-K | 5.02 | 0001564590-22-023555 | 001-39567 | 221023780 | 34 | 163186 | 1 | 1 |
| 2022-06-14 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-036718 | 5071 | ||||||
| 2022-06-14 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-036716 | 5083 | ||||||
| 2022-06-14 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-036715 | 5097 | ||||||
| 2022-06-14 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-036714 | 5097 | ||||||
| 2022-06-14 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-036713 | 5087 | ||||||
| 2022-06-14 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-036712 | 5090 | ||||||
| 2022-06-14 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-036711 | 5092 | ||||||
| 2022-06-10 | SC 13G | arrowmark-cccc060222.htm | 0001172661-22-001528 | 005-91763 | 221007721 | 34 | 53953 | |||
| 2022-06-06 | SC 13G/A | cccc622.txt | 0000814133-22-000100 | 005-91763 | 22997466 | 34 | 3984 | |||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032515 | 7154 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032514 | 7173 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032512 | 7170 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032511 | 7180 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032509 | 7180 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032510 | 7175 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032508 | 7170 | ||||||
| 2022-05-16 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-020438 | 001-39567 | 22930461 | 34 | 202902 | 1 | 1 |
| 2022-05-12 | DEFA14A | DEFA14A | 0001193125-22-148612 | 001-39567 | 22917655 | 34 | 10800 | |||
| 2022-05-05 | 10-Q | 10-Q | 0001564590-22-018046 | 001-39567 | 22894196 | 34 | 9226386 | 1 | 1 | |
| 2022-05-05 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-018044 | 001-39567 | 22894175 | 34 | 1890103 | 1 | 1 |
| 2022-04-29 | DEFA14A | DEFA14A | 0001193125-22-130943 | 001-39567 | 22870756 | 34 | 406511 | |||
| 2022-04-29 | DEF 14A | DEF 14A | 0001193125-22-130938 | 001-39567 | 22870738 | 34 | 1559043 | |||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024228 | 10820 | ||||||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024130 | 4543 | ||||||
| 2022-04-08 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-013950 | 001-39567 | 22816334 | 34 | 7977508 | 1 | 1 |
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023021 | 7277 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023018 | 5872 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023016 | 9745 | ||||||
| 2022-03-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-019573 | 5368 | ||||||
| 2022-03-17 | 3 | FORM 3 SUBMISSION | 0001209191-22-019572 | 7262 | ||||||
| 2022-03-17 | 3 | FORM 3 SUBMISSION | 0001209191-22-019571 | 11188 | ||||||
| 2022-03-17 | 3 | FORM 3 SUBMISSION | 0001209191-22-019569 | 9977 | ||||||
| 2022-03-16 | 8-K | 8-K | 5.02,7.01,9.01 | 0001564590-22-010644 | 001-39567 | 22745048 | 34 | 208589 | 1 | 1 |
| 2022-02-24 | S-8 | S-8 | 0001564590-22-006505 | 333-262949 | 22666581 | 33 | 165295 | |||
| 2022-02-24 | 10-K | 10-K | 0001564590-22-006499 | 001-39567 | 22666557 | 34 | 23997901 | 1 | 1 | |
| 2022-02-24 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-006496 | 001-39567 | 22666525 | 34 | 297554 | 1 | 1 |
| 2022-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-012216 | 5605 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010206 | 8018 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010208 | 8017 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010207 | 7986 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010204 | 8010 | ||||||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-042235 | 005-91763 | 22634956 | 34 | 67945 | |||
| 2022-02-14 | SC 13G/A | schedule13g.htm | 0000929638-22-000485 | 005-91763 | 22630252 | 34 | 109255 |
One latest value per concept from companyfacts (291 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 131.32M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 100.05M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 846,679 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001628280-26-028104 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.56M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001628280-26-028104 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 1.32M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001628280-26-028104 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 2.94M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001628280-26-028104 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 32.37 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001628280-26-028104 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 963,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 1.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 6.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 14.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 870,000 | 2023-06-30 | 2023 | Q1 | 10-Q | 2023-08-08 | 0001628280-23-027941 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 11.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.04B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 26,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.98M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 8.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008433 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 117.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | Assets | Assets | USD | 331.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 214.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 296.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 379.30M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 375.65M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 316.46M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001628280-22-027985 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 32.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 63.43M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 274.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 35.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -26.57M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001628280-22-027985 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -42.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 8.86 | 2020-10-06 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 131.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 131.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 13,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -71.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 33.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 19.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 13.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 10.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod | Contract with Customer, Performance Obligation Satisfied in Previous Period | USD | 1.34M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 256.52M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 13.42M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 121,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 121,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 11.00M | 2023-06-30 | 2023 | Q1 | 10-Q | 2023-08-08 | 0001628280-23-027941 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 1.02M | 2022-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0001628280-24-006144 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001628280-22-027985 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | USD | 243.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent | USD | 321.87M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001628280-22-027985 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | security | 0 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001628280-23-004711 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | USD | 242.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | USD | 172.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent | USD | 69.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 111.93M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 59,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security | 68 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 12.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 50.29M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 31.27M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 19.02M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 6.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 216.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 100.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 359.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 359.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 474.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 22,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsForeign | Deferred Tax Assets, Tax Credit Carryforwards, Foreign | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008433 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 27.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 13.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxAssetsUnrealizedLossesOnTradingSecurities | Deferred Tax Assets, Unrealized Losses on Trading Securities | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0001628280-24-006144 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 203.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 1.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities | Deferred Tax Liabilities, Unrealized Gains on Trading Securities | USD | 3,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 1.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.03 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.9 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | Depreciation | Depreciation | USD | 1.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1.96M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.65 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.22 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.018 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.01 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008433 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.028 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxSettlements | Effective Income Tax Rate Reconciliation, Tax Settlement, Percent | pure | -0.01 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 72.80M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 5.68M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 | |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 5.46M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | -16,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008433 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 26.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -104.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008433 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 131,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority | Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority | USD | 600,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 131,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 23.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -22.02M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 52,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 4,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 95,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 3.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 105,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -996,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 828,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 4.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -4.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 8.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | InterestExpenseBorrowings | Interest Expense, Borrowings | USD | 1.00M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008433 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008433 |
| us-gaap | InvestmentsFairValueDisclosure | Investments, Fair Value Disclosure | USD | 135.98M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 10.76M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 71.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 15.55M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 9.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 12.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 12.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 11.36M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 9.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 2.09M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001628280-22-027985 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 11.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | Liabilities | Liabilities | USD | 103.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 331.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 41.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 11.48M | 2022-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0001628280-24-006144 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0001628280-24-006144 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 9.50M | 2023-06-30 | 2023 | Q1 | 10-Q | 2023-08-08 | 0001628280-23-027941 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 9.50M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 9.50M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 9.50M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001628280-23-004711 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 1.50M | 2023-06-30 | 2023 | Q1 | 10-Q | 2023-08-08 | 0001628280-23-027941 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0001628280-24-006144 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 365.50M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 264.10M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001628280-22-027985 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 52.36M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001628280-22-027985 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -619,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 34.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -19.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -57.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -70.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -83.89M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 8.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 100.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -78.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 9.75M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 10.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 59.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 6.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 48.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 7.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 36.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 4.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.053 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 4.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -1.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -3,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 989,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 44,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | 68,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale | USD | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 239,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001628280-23-004711 |
| us-gaap | PaymentsForUnderwritingExpense | Payments for Underwriting Expense | USD | 14.70M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 500,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 8.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 180.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 101,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 135.93M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 8.47M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 7.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 195.07M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 33.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 145.53M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 11.97M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | 229,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 161.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments | Proceeds from Sale, Maturity and Collection of Short-term Investments | USD | 14.90M | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 63,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 2,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -70.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 15.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 3.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 1.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008433 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 73.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 3.44M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001628280-26-033865 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 3.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | RestructuringAndRelatedCostCostIncurredToDate1 | Restructuring and Related Cost, Cost Incurred to Date | USD | 2.40M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001628280-25-049854 | |
| us-gaap | RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated | Restructuring and Related Cost, Expected Number of Positions Eliminated | position | 45 | 2024-01-01 | 2024-03-31 | 2023 | Q1 | 10-Q | 2024-05-08 | 0001628280-24-021368 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.3 | 2024-01-09 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001628280-25-049854 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 800,000 | 2024-03-31 | 2023 | Q1 | 10-Q | 2024-05-08 | 0001628280-24-021368 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -809.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer | Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer | USD | 7.65M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 21.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0001628280-24-006144 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 8.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.12M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 15.48 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 395,676 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 730,270 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.99 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 5.88M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 21.29 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 5.88M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 21.29 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 4.14 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 13.55 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 3.8 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | SharePrice | Share Price | USD/shares | 26.96 | 2020-10-06 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 135.98M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 228.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.119 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 380,688 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056223 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 256.52M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 173,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 33.55M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | -39,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 225,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 6,634 | 2024-01-01 | 2024-09-30 | 2023 | Q1 | 10-Q | 2024-10-31 | 0001628280-24-044411 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | -78,000 | 2020-04-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043442 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 1.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate | Tax Cuts and Jobs Act, Measurement Period Adjustment, Increase (Decrease) in Effective Tax Rate | pure | 0.8 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001564590-22-006499 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 111.00M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 111.00M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 146.76M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 113.15M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 113.15M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012531 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 53,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053604 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 30.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 2.65M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 130.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 48.73M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018046 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 76.92M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012000 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 130.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001628280-26-070575 |